Manatt Health Partner Michael Kolber will speak on a panel session titled, “Moving Toward Weight-Loss Equity,” at the upcoming MM+M Transform Conference from 10-10:50 am EST on April 3, 2024.

Some 42% of U.S. adults and 20% of children and adolescents have obesity, according to the CDC. Yet Medicare and Medicaid are still bound by a 2003 law that excludes coverage of medicine for weight loss. With commercial insurers usually following the lead of the public ones, the new GLP-1 obesity drugs remain out of reach for many patients. Now that science has gained a better understanding of obesity’s various metabolic implications and potential downstream health benefits - from cardiovascular disease and type 2 diabetes to liver disease and certain types of cancer - additional indications for these drugs are on the way. What will it take for the Centers for Medicare and Medicaid Services to rethink this policy?

To learn more and register, click here.